IRICoR | An Innovative Approach to Drug Discovery

Great partnerships create great opportunities!

2023 BIO International Convention

ELIZABETH DOUVILLE APPOINTED PRESIDENT AND CHIEF EXECUTIVE OFFICER OF IRICoR

Ipsen, UdeM and IRICoR broaden existing oncology partnership, with an exclusive license agreement and two new discovery-stage programs

New Strategic Investment of IRICoR in RejuvenRx Spin-off

Dre Gwenaëlle Gavory joins the IRICoR team

Intellectual property management: a formidable marketing lever for anticancer therapies

New VP – Scientific Operations at IRICoR

IRICoR welcomes the appointment of Nadine Beauger as a member of the Board of Directors of Canada’s Stem Cell Network